MRM Health

📢 #VIBspinoff @HealthMrm announces positive Phase 2 results in mild-to-moderate #UlcerativeColitis. The trial demonstrated an excellent safety profile and initial efficacy on disease activity evidenced in clinically relevant parameters. 👇 vibbio.tech/45Vx3uY

Another milestone for MRM Health: Today we announced positive results from our Phase 2a study with MH002 in mild-to-moderate Ulcerative Colitis! Discover more: businesswire.com/news/home/2023… #MH002 #UlcerativeColitis #microbiome #therapeutics

Welcome to the team Katja! Press release: mrmhealth.com/news.html #microbiome #ulcerativecolitis #therapeutics #biotech

Proud to be one of the 25 innovative & disruptive companies selected to pitch during the Health Tech Innovation days in Paris (Oct 13-14, 2022)! #HTID #Microbiome #IBD #innovation #biotech

Our second clinical trial has been approved by the Belgian regulators (FAMHP)!! This phase 2 study in Pouchitis is a multi-center, open label trial which will enrol up to 20 acute Pouchitis patients. Read about it here: shorturl.at/gvAHU #microbiome #microbiota #pouchitis

Read about some of our exciting liver disease work here at MRM Health. Results from a collaboration with the Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d’Hebron have just been published. mdpi.com/2227-9059/10/5… #microbiome #nafld #gutliveraxis

Our CEO, Sam Possemiers, and our CSO, Nigel Horscroft, will be presenting at the 6th #Microbiome Movement Drug Development Summit next week. The presentations will cover our programs in #IBD, #NAFLD/#NASH, Type 2 #Diabetes and #Parkinson’s Disease microbiome-summit.com

We're very proud to be recognized as the Best emerging Clinical-stage Biotech Company – 2022 by Corporate Vision Magazine! Check out our pipeline at mrmhealth.com to see our plans for the future. @Corp_Vision #microbiome #Biotech #therapeutics

We are very proud to announce that the first patient has been dosed in a phase 1b/2a trial in Ulcerative Colitis. MH002 is our first clinical candidate resulting from our proprietary CORAL™ platform technology. #biotechnology #ulcerativecolitis #clinicaltrial #microbiome

Want to learn more about our Phase 1b/2a #clinicaltrial in #UlcerativeColitis? If you're at the 9th #Microbiome R&D and Business Collaboration Forum in Rotterdam on Tuesday 26th October then come along to hear #MRMHealth CEO and co-founder Sam Possemiers tell all

Today we announce another milestone for MRM Health. Our CTA for a Phase 1b/2a clinical trial in Ulcerative Colitis has been approved! shorturl.at/nuzAJ #mrmhealth #IBD #ulcerativecolitis #microbiome #biopharma #clinicaltrial #inflammatoryboweldisease #guthealth

Meet MRM Health at BioEquity Europe May 17-19 (online) to learn how we are redefining microbiome therapeutics #health #healthcare #microbiome #mrmhealth #medicine #biotechnology #bioequity #ibd #ulcerativecolitis #autoimmunedisease #neuroinflammation

Our CEO and co-founder, Sam Possemiers, will be presenting "MRM Health – the Next Level in Optimized Consortia Development" in the Biotech Showcase at Pharmabiotics 2021 on April 28th & 29th #biotech #healthcare #mrmhealth #microbiome #therapeutics #ulcerativecolitis

bloovi.be/artikels/onder… #innovation #startups #microbiome #biotech #biotechnology #therapeutics #biosciences #lifesciences

How gut microbes could drive brain disorders nature.com/articles/d4158…

We presented our proprietary microbiome therapeutics technology and pipeline at the Microbiome Movement Drug Development Conference. mrmhealth.com/docs/MRM%20Hea… #biotech #microbiome #biotechnology #therapeutics #biosciences #lifesciences #inflammatoryboweldisease #ulcerativecolitis

Proud to recognised as a pharma start-up to be watched in 2021!! startus-insights.com/innovators-gui… #MRMHealth #microbiome #therapeutics #drugdiscovery #Gut #Health

MRM Health Corporate Video youtu.be/bouC52ZkaTg via @YouTube #MRMHealth #ProDigest #microbiome #therapeutics #drugdiscovery #gut #Health #shime